Evidence map›Paper›PMID 28249066›Full record

ArticleJAMA dermatology2017

Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013.

Chante Karimkhani, Robert P Dellavalle, Luc E Coffeng, Carsten Flohr, Roderick J Hay, Sinéad M Langan, Elaine O Nsoesie, Alize J Ferrari, Holly E Erskine, Jonathan I Silverberg and 2 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in JAMA dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 288 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
288citing papers in PubMed, 7 pooled it
33.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03866447 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Vitamin D and Its Topical Analogues: A Possible Role in the Pathogenesis and Treatment of Acne Vulgaris

TypeinterventionalSponsorAssiut UniversityRan2019 to 2021Enrolled80ConditionsAcne VulgarisArmsVitamin D analog, Adapalene
NCT07575464 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of the Efficacy of Auricular Acupressure Combined With Antihistamines in Patients With Wind-Heat Type Urticaria

TypeinterventionalSponsorUniversity of Medicine and Pharmacy at Ho Chi Minh CityRan2026 to 2026Enrolled66ConditionsAuricular Acupressure, Wind-Heat Urticaria, Traditional MedicineArmsTrue Auricular Acupressure, Sham Auricular Acupressure, Loratadine 10mg
3 · Its place in the literature

Who cites it

288 citing papers in PubMed, 7 syntheses or guidelines pooled it, 695 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Solid Hydrogel Couplants for Skin Superficial Blood Flow Imaging With Super-Resolution Ultrasound.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

228 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 4 countries.

Chante KarimkhaniUniversity Hospitals Case Western Medical Center, Cleveland, Ohio2now with Department of Dermatology, University of Colorado, Denver.
Robert P DellavalleDermatology Service, US Department of Veterans Affairs, Eastern Colorado Health Care System, Denver4University of Colorado School of Medicine, Aurora5Colorado School of Public Health, Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora.
Luc E CoffengInstitute for Health Metrics and Evaluation, University of Washington, Seattle7Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Carsten FlohrUnit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
Roderick J HayDepartment of Dermatology, Kings College NHS Trust, London, United Kingdom.
Sinéad M LanganFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Elaine O NsoesieInstitute for Health Metrics and Evaluation, University of Washington, Seattle.
Alize J FerrariInstitute for Health Metrics and Evaluation, University of Washington, Seattle11School of Public Health, University of Queensland, Herston, Queensland, Australia12Queensland Centre for Mental Health Research, Wacol, Queensland, Australia.
Holly E ErskineInstitute for Health Metrics and Evaluation, University of Washington, Seattle11School of Public Health, University of Queensland, Herston, Queensland, Australia12Queensland Centre for Mental Health Research, Wacol, Queensland, Australia.
Jonathan I SilverbergDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois14Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois15Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Theo VosInstitute for Health Metrics and Evaluation, University of Washington, Seattle.
Mohsen NaghaviInstitute for Health Metrics and Evaluation, University of Washington, Seattle.
Institute for Health Metrics and Evaluation · USUniversity of Queensland · AUUniversity of Washington · USKing's College Hospital · GBKing's College London · GBLondon School of Hygiene & Tropical Medicine · GBNorthwestern University · USUniversity of Colorado Denver · USVA Eastern Colorado Health Care System · US

Funding

Department of Health NIHR/CS/010/014
6 · The paper itself

Abstract

Importance: Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes estimates of global morbidity and mortality due to skin diseases. Objective: To measure the burden of skin diseases worldwide. Data Sources: For nonfatal estimates, data were found by literature search using PubMed and Google Scholar in English and Spanish for years 1980 through 2013 and by accessing administrative data on hospital inpatient and outpatient episodes. Data for fatal estimates were based on vital registration and verbal autopsy data. Study Selection: Skin disease data were extracted from more than 4000 sources including systematic reviews, surveys, population-based disease registries, hospital inpatient data, outpatient data, cohort studies, and autopsy data. Data metrics included incidence, prevalence, remission, duration, severity, deaths, and mortality risk. Data Extraction and Synthesis: Data were extracted by age, time period, case definitions, and other study characteristics. Data points were modeled with Bayesian meta-regression to generate estimates of morbidity and mortality metrics for skin diseases. All estimates were made with 95% uncertainty intervals. Main Outcomes and Measures: Disability-adjusted life years (DALYs), years lived with disability, and years of life lost from 15 skin conditions in 188 countries. Results: Skin conditions contributed 1.79% to the global burden of disease measured in DALYs from 306 diseases and injuries in 2013. Individual skin diseases varied in size from 0.38% of total burden for dermatitis (atopic, contact, and seborrheic dermatitis), 0.29% for acne vulgaris, 0.19% for psoriasis, 0.19% for urticaria, 0.16% for viral skin diseases, 0.15% for fungal skin diseases, 0.07% for scabies, 0.06% for malignant skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte carcinoma, 0.03% for decubitus ulcer, and 0.01% for alopecia areata. All other skin and subcutaneous diseases composed 0.12% of total DALYs. Conclusions and Relevance: Skin and subcutaneous diseases were the 18th leading cause of global DALYs in Global Burden of Disease 2013. Excluding mortality, skin diseases were the fourth leading cause of disability worldwide.

Indexed as

Global Burden of DiseaseGlobal HealthAdolescentAdultAgedAged, 80 and overBayes TheoremChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedPersons with Disabilities

Identifiers

PMID28249066
PMCPMC5817488
OpenAlexW2594455611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.